The breast cancer tumor suppressor BRCA1 contains two highly conserved functional domains at its termini: the N-terminal RING domain and the C-terminal BRCT motifs. Human genetics studies suggest that both of these domains are important for BRCA1 tumor suppression functions. It is believed that the major roles of BRCA1 are involved in the maintenance of genomic stability, which is at least partially mediated by its involvement in DNA damage repair and cell cycle checkpoint control. Several years ago, we and others demonstrated that the C-terminal BRCT domain is a phospho-peptide binding domain. Subsequently we and others have shown that BRCA1 uses its BRCT domain to form three independent subcomplexes. These complexes have been named respectively BRCA1-A, BRCA1-B and BRCA1-C complexes. The BRCA1-A complex consists of RAP80, CCDC98/ABRAXAS, BRCC36, BRCC45 and MERIT40/NBA1. This complex is mainly involved in the stable accumulation of BRCA1 at sites of DNA double-strand breaks. The BRCA1-B complex contains DNA helicase BACH1 and topoisomerase II-binding protein 1 (TOPBP1). This complex is likely to act in S phase and regulate S phase progression in response to DNA damage. The BRCA1-C complex comprises CtIP and MRE11-RAD50-NBS1 (MRN) complex, which plays an essential role in damage detection, ATM activation and DNA damage repair. The framework, that BRCA1 exerts its tumor suppression functions by its participation in multiple BRCA1-containing protein complexes, has been established. In this proposal, we will further study the regulations and functions of BRCA1. We propose to: 1) explore how BRCA1-A complex and its associated DUB activity participate in the maintenance of genomic stability and tumor suppression;2) determine the roles of BRCA1 RING domain and its E3 ligase activity in DNA damage repair;3) identify and study new BRCA1/BARD1-associated protein complexes involved in DNA damage response and tumor suppression.
Breast cancer tumor suppressor BRCA1 interacts with many binding partners and participates in a variety of cellular processes to ensure genomic integrity. In this grant application, we will study the regulation and function of BRCA1 E3 ligase activity and BRCA1-associated protein complexes in DNA damage response. We hope that these studies will reveal the molecular mechanisms underlying BRCA1 tumor suppressor functions.
|Li, Nan; Feng, Lin; Liu, Hui et al. (2016) PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2. Cell Rep :|
|Lee, Yuan-Cho; Zhou, Qing; Chen, Junjie et al. (2016) RPA-Binding Protein ETAA1 Is an ATR Activator Involved in DNA Replication Stress Response. Curr Biol 26:3257-3268|
|Li, Xu; Wang, Wenqi; Xi, Yuanxin et al. (2016) FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis. Cell Rep 16:487-97|
|Li, Xu; Wang, Wenqi; Chen, Junjie (2015) From pathways to networks: connecting dots by establishing protein-protein interaction networks in signaling pathways using affinity purification and mass spectrometry. Proteomics 15:188-202|
|Wang, Wenqi; Li, Nan; Li, Xu et al. (2015) Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins. Cell Rep 13:524-32|
|Wang, Wenqi; Xiao, Zhen-Dong; Li, Xu et al. (2015) AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol 17:490-9|
|Wang, Wenqi; Li, Xu; Lee, Moonsup et al. (2015) FOXKs promote Wnt/Î²-catenin signaling by translocating DVL into the nucleus. Dev Cell 32:707-18|
|Wang, Wenqi; Li, Xu; Huang, Jun et al. (2014) Defining the protein-protein interaction network of the human hippo pathway. Mol Cell Proteomics 13:119-31|
|Wang, Jiadong; Aroumougame, Asaithamby; Lobrich, Markus et al. (2014) PTIP associates with Artemis to dictate DNA repair pathway choice. Genes Dev 28:2693-8|
|Li, Yujing; Fong, Ka-Wing; Tang, Mengfan et al. (2014) Fam118B, a newly identified component of Cajal bodies, is required for Cajal body formation, snRNP biogenesis and cell viability. J Cell Sci 127:2029-39|
Showing the most recent 10 out of 70 publications